Natera Partners with NVIDIA to Advance AI in Precision Medicine

Reuters01-12
Natera Partners with NVIDIA to Advance AI in Precision Medicine

Natera Inc., a global leader in cell-free DNA testing and precision medicine, has announced a collaboration with NVIDIA to accelerate the development of Natera's multimodal AI foundation model platform. The partnership will integrate Natera's extensive longitudinal and multi-time point in vivo datasets with NVIDIA's high-performance computing platforms and AI frameworks. This collaboration aims to establish advanced computational infrastructure for training and deploying large-scale AI models on complex medical datasets, enhancing precision diagnostics, therapeutic insights, and personalized medicine applications.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Natera Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20260112000650) on January 12, 2026, and is solely responsible for the information contained therein.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment